OTCA26 Obesity Surgery Project – Final Assessment now available
The final report is now available for the Relative Effectiveness Assessment OTCA26 “Surgical procedures for treatment of obesity”. The aim of this multi-technology HTA was to assess the comparative effectiveness (and possible superiority) and safety of different surgical treatments for adult patients with obesity (AGB, SG, RYGB, D-RYGB, OAGB, BPD-DS, BPD,SASI, SADI-S). Only data from […]
OTCA25 Final Report and related documents now available
The final report for the Relative Effectiveness Assessment OTCA 25 “Stereotactic body radiation therapy (SBRT) for the treatment of lung, prostate and liver cancer”, is now available for access. The aim of this HTA was to assess if the use of SBRT is more effective and safer compared to radiotherapy (RT), surgery, or surgery and […]
OTCA27 – Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia (BPH)- final report now available
The final report is now available for the Relative Effectiveness Assessment OTCA27 “Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia (BPH)”. The aim of this multi-technology HTA was to assess 21 minimally invasive surgical treatments for benign prostatic hyperplasia (BPH), either comparing minimally invasive treatments to each other or […]
OTCA28 – ‘Lung cancer screening in risk groups’ – final assessment now available
We are pleased to announce that the collaborative assessment, OTCA28 – ‘Lung cancer screening in risk groups’ – is now available. The aim of this EUnetHTA Assessment is to provide a reliable synthesis and analysis of the available evidence on lung cancer screening in risk groups (persons with history of smoking or current smokers, persons […]
OTCA23 Final Assessment Report “Biodegradable rectum spacers to reduce toxicity for prostate cancer” now available
The Other Technologies Collaborative Assessment OTCA23 final assessment report “Biodegradable rectum spacers to reduce toxicity for prostate cancer”, together with related documentation, is now available for access. The assessed technology is biodegradable rectum spacers added to conventional radiotherapy to (temporarily) position the prostate away from the rectum with the aim of reducing the side effects […]
OTJA10 – Final Assessment report and related documents are now available
EUnetHTA started an “Error reporting and correction” procedure on 04/05/2020. The reported error was not classified as an error by EUnetHTA and the Assessment Team, therefore no changes to the assessment report were needed. The comments received including the answers from the authoring team are published for transparency reasons. See here. We are pleased to […]
OTCA15 – Final Assessment and input from external experts and manufacturers are now available
We are pleased to announce that the final assessment for OTCA15 “Irreversible electroporation in liver and pancreatic cancer”, together with the input from external experts and manufacturers, are now available for access. Irreversible electroporation (IRE) is a nonthermal ablative method based on the application of short high-voltage and low-frequency electric fields to destroy tissue. The purpose of […]
Open Call for Patient Group Input – Collaborative Assessment on a Medical Device for Rectum Spacers for Prostate Cancer Radiotherapy
EUnetHTA recently started a new Collaborative Assessment on a Medical Device for rectum spacers for prostate cancer radiotherapy. To find out about participation, please read more here. Input submissions will be received through EOB, Friday 5th July.
